#GoldenCross $COLL at 19.34 R13 HiLo 56% T1Y 28 buy PE 19340.0 DIV N/A #Collegium #stocks #trading #finance #market

2020-10-24
52 Views

Golden Cross detected for COLL (Collegium Pharmaceut) at the close price of 19.34. Trading at a 56 % level between the 52week High (25.59) and 52week Low (11.52). The average analyst 1-year target price is 28.0 with an average buy and a score of 0.0.

Golden Cross
13 %
COLL
19.34
Collegium Pharmaceut
HiLo
55.6 %
Support
18.87
Resistance
22.29
50DMA
19.51
200DMA
19.47
52week high
25.59
52week low
11.52
10DMA
20.38
20DMA
20.68
100 Mean
18.53
Volume
165846
AvgDayVol
338386
MarketCap
667725120
EBITDA
48098000
Revenue
301713984
PE
19340.00
P2S
0.00
P2B
0.00
Dividend
0.00
Div Ex-Date

Further research links:

Marketwatch Yahoo Finance Google Finance StockTwits

You may be interested

HILO Index 237 Current 182.15 MA20 9.34 Lower 187.3 Upper Bound #stocks #trading #markets #finance
Bear, Global Indicators
7 views
Bear, Global Indicators
7 views

HILO Index 237 Current 182.15 MA20 9.34 Lower 187.3 Upper Bound #stocks #trading #markets #finance

Andreas Aigner - 2020-12-02

[Bearish] HILO Index 237 Current 182.15 MA20 9.34 Lower 187.3 Upper Bound #stocks #trading #markets #finance x

Demark B/S Index -1.92 Avg 33.26 Std 1 Curr #stocks #trading #markets #finance
Global Indicators,
7 views
Global Indicators,
7 views

Demark B/S Index -1.92 Avg 33.26 Std 1 Curr #stocks #trading #markets #finance

Andreas Aigner - 2020-12-02

Demark B/S Index -1.92 Avg 33.26 Std 1 Curr #stocks #trading #markets #finance

50/200 DMA Index 4.22 Avg 6.81 Std 3 Curr #stocks #trading #markets #finance
Global Indicators,
9 views
Global Indicators,
9 views

50/200 DMA Index 4.22 Avg 6.81 Std 3 Curr #stocks #trading #markets #finance

Andreas Aigner - 2020-12-02

50/200 DMA Index 4.22 Avg 6.81 Std 3 Curr #stocks #trading #markets #finance x

Leave a Comment

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

We use Cookies to improve our Site. Your are agreeing to this by continuing to use our Site.